In addition, we have confirmed that this exosome has good safety and targeting properties through experiments and found that si-PDGFRβ-loaded exosomes inhibited the glioma progression through PI3K/Akt/EZH2 signaling pathway. The gene discussed is EZH2; the disease is central nervous system cancer.